Biogen (BIIB) Ratios
Biogen Ratios
MX:BIIB's free cash flow for Q3 2026 was $600.40M. For the 2026 fiscal year, MX:BIIB's free cash flow was decreased by $-40.40M and operating cash flow was $640.80M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.68 | 1.35 | 2.00 | 2.99 | 1.83 |
| Quick Ratio | 2.03 | 0.90 | 1.26 | 2.58 | 1.51 |
| Cash Ratio | 0.90 | 0.43 | 0.31 | 1.04 | 0.53 |
| Solvency Ratio | 0.19 | 0.20 | 0.14 | 0.32 | 0.16 |
| Operating Cash Flow Ratio | 0.66 | 0.52 | 0.45 | 0.42 | 0.85 |
| Short-Term Operating Cash Flow Coverage | 27.42 | 1.64 | 10.31 | 0.00 | 3.64 |
| Net Current Asset Value | $ -2.21B | $ -3.88B | $ -5.19B | $ -1.37B | $ -5.06B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.24 | 0.24 | 0.27 | 0.27 | 0.32 |
| Debt-to-Equity Ratio | 0.38 | 0.40 | 0.50 | 0.49 | 0.70 |
| Debt-to-Capital Ratio | 0.28 | 0.28 | 0.33 | 0.33 | 0.41 |
| Long-Term Debt-to-Capital Ratio | 0.26 | 0.21 | 0.31 | 0.32 | 0.37 |
| Financial Leverage Ratio | 1.61 | 1.68 | 1.81 | 1.83 | 2.19 |
| Debt Service Coverage Ratio | 8.69 | 1.36 | 5.65 | 11.78 | 3.09 |
| Interest Coverage Ratio | 7.63 | 9.95 | 8.49 | 11.72 | 11.01 |
| Debt to Market Cap | 0.26 | 0.28 | 0.19 | 0.16 | 0.20 |
| Interest Debt Per Share | 49.04 | 47.22 | 52.42 | 47.22 | 52.70 |
| Net Debt to EBITDA | 1.34 | 1.42 | 2.65 | 0.90 | 1.36 |
| Profitability Margins | |||||
| Gross Profit Margin | 70.47% | 76.12% | 74.24% | 77.61% | 80.79% |
| EBIT Margin | 22.07% | 24.00% | 19.14% | 29.67% | 31.29% |
| EBITDA Margin | 30.02% | 30.96% | 24.17% | 34.77% | 35.73% |
| Operating Profit Margin | 19.14% | 25.74% | 21.32% | 28.40% | 25.42% |
| Pretax Profit Margin | 14.29% | 19.70% | 13.18% | 35.33% | 16.21% |
| Net Profit Margin | 13.18% | 16.87% | 11.81% | 29.95% | 14.17% |
| Continuous Operations Profit Margin | 13.18% | 16.87% | 11.81% | 29.11% | 15.73% |
| Net Income Per EBT | 92.29% | 85.63% | 89.54% | 84.77% | 87.42% |
| EBT Per EBIT | 74.65% | 76.54% | 61.83% | 124.41% | 63.77% |
| Return on Assets (ROA) | 4.39% | 5.82% | 4.33% | 12.41% | 6.52% |
| Return on Equity (ROE) | 7.08% | 9.76% | 7.85% | 22.74% | 14.28% |
| Return on Capital Employed (ROCE) | 7.20% | 11.06% | 8.96% | 13.58% | 14.26% |
| Return on Invested Capital (ROIC) | 6.62% | 8.79% | 7.97% | 11.19% | 13.16% |
| Return on Tangible Assets | 9.39% | 13.74% | 9.47% | 17.97% | 9.79% |
| Earnings Yield | 5.01% | 7.33% | 3.10% | 7.57% | 4.35% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.25 | 5.18 | 4.68 | 4.76 | 5.60 |
| Payables Turnover | 6.71 | 5.45 | 6.28 | 4.64 | 3.58 |
| Inventory Turnover | 1.34 | 0.94 | 1.00 | 1.69 | 1.56 |
| Fixed Asset Turnover | 2.95 | 2.74 | 2.64 | 2.75 | 2.90 |
| Asset Turnover | 0.33 | 0.34 | 0.37 | 0.41 | 0.46 |
| Working Capital Turnover Ratio | 2.60 | 3.62 | 1.98 | 2.02 | 3.28 |
| Cash Conversion Cycle | 288.20 | 392.19 | 383.96 | 213.29 | 197.09 |
| Days of Sales Outstanding | 69.46 | 70.50 | 77.93 | 76.65 | 65.20 |
| Days of Inventory Outstanding | 273.16 | 388.71 | 364.14 | 215.38 | 233.82 |
| Days of Payables Outstanding | 54.43 | 67.02 | 58.11 | 78.74 | 101.94 |
| Operating Cycle | 342.63 | 459.21 | 442.07 | 292.03 | 299.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 15.03 | 19.74 | 10.69 | 9.53 | 24.41 |
| Free Cash Flow Per Share | 13.98 | 17.27 | 8.54 | 7.87 | 22.68 |
| Dividend Paid and CapEx Coverage Ratio | 14.33 | 7.99 | 4.97 | 5.76 | 14.10 |
| Capital Expenditure Coverage Ratio | 14.33 | 7.99 | 4.97 | 5.76 | 14.10 |
| Operating Cash Flow Coverage Ratio | 0.32 | 0.43 | 0.21 | 0.21 | 0.48 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.30 | 0.16 | 0.14 | 0.33 |
| Free Cash Flow Yield | 7.94% | 11.29% | 3.30% | 2.84% | 9.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.89 | 13.65 | 32.25 | 13.21 | 22.99 |
| Price-to-Sales (P/S) Ratio | 2.63 | 2.30 | 3.81 | 3.96 | 3.26 |
| Price-to-Book (P/B) Ratio | 1.41 | 1.33 | 2.53 | 3.00 | 3.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.59 | 8.86 | 30.30 | 35.17 | 10.58 |
| Price-to-Operating Cash Flow Ratio | 11.71 | 7.75 | 24.20 | 29.07 | 9.83 |
| Price-to-Earnings Growth (PEG) Ratio | -0.95 | 0.34 | -0.52 | 0.13 | -0.40 |
| Enterprise Value Multiple | 10.10 | 8.86 | 18.40 | 12.28 | 10.48 |
| Enterprise Value | 29.76B | 26.54B | 43.73B | 43.43B | 41.11B |
| EV to EBITDA | 10.10 | 8.86 | 18.40 | 12.28 | 10.48 |
| EV to Sales | 3.03 | 2.74 | 4.45 | 4.27 | 3.74 |
| EV to Free Cash Flow | 14.51 | 10.55 | 35.39 | 37.96 | 12.16 |
| EV to Operating Cash Flow | 13.50 | 9.23 | 28.27 | 31.37 | 11.30 |
| Tangible Book Value Per Share | 17.64 | 3.75 | 1.50 | 39.84 | 19.97 |
| Shareholders’ Equity Per Share | 124.45 | 114.73 | 102.28 | 92.21 | 73.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.08 | 0.14 | 0.10 | 0.18 | 0.03 |
| Revenue Per Share | 66.88 | 66.41 | 67.97 | 70.02 | 73.65 |
| Net Income Per Share | 8.82 | 11.20 | 8.02 | 20.97 | 10.44 |
| Tax Burden | 0.92 | 0.86 | 0.90 | 0.85 | 0.87 |
| Interest Burden | 0.65 | 0.82 | 0.69 | 1.19 | 0.52 |
| Research & Development to Revenue | 0.20 | 0.26 | 0.27 | 0.26 | 0.31 |
| SG&A to Revenue | 0.25 | 0.25 | 0.25 | 0.23 | 0.24 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| Income Quality | 1.71 | 1.76 | 1.33 | 0.47 | 2.11 |
Currency in USD